Health Cor Management, L.P. Jounce Therapeutics, Inc. Transaction History

Health Cor Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.04 - $8.73 $1.35 Million - $2.34 Million	-268,295 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.58 - $10.66 $432,371 - $700,468	65,710 Added 32.44%	268,295 $1.82 Million
Q1 2021 May 17, 2021	BUY	$6.73 - $13.87 $1.36 Million - $2.81 Million	202,585 New	202,585 $2.08 Million

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.